Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial. (Q46639368)
Jump to navigation
Jump to search
scientific article published in May 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial. |
scientific article published in May 2008 |
Statements
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial (English)
Antoni Torres
Pierre Arvis
Jean Carlet
Shurjeel Choudhri
Amar Kureishi
Marie-Aude Le Berre
Hartmut Lode
John Winter
MOTIV (MOxifloxacin Treatment IV) Study Group